FR2739560B1 - USE OF A POLYPEPTIDE HAVING SOLUBLE HUMAN CD16 ACTIVITY IN THE TREATMENT OF HIV VIRUS INFECTION - Google Patents

USE OF A POLYPEPTIDE HAVING SOLUBLE HUMAN CD16 ACTIVITY IN THE TREATMENT OF HIV VIRUS INFECTION

Info

Publication number
FR2739560B1
FR2739560B1 FR9511860A FR9511860A FR2739560B1 FR 2739560 B1 FR2739560 B1 FR 2739560B1 FR 9511860 A FR9511860 A FR 9511860A FR 9511860 A FR9511860 A FR 9511860A FR 2739560 B1 FR2739560 B1 FR 2739560B1
Authority
FR
France
Prior art keywords
polypeptide
activity
treatment
virus infection
hiv virus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR9511860A
Other languages
French (fr)
Other versions
FR2739560A1 (en
Inventor
Wolf H Fridman
Jerome Galon
Cavaillon Nicole Haeffner
Michel D Kazatchkine
Catherine Sautes
Nathalie Thieblemont
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis France
Original Assignee
Roussel Uclaf SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roussel Uclaf SA filed Critical Roussel Uclaf SA
Priority to FR9511860A priority Critical patent/FR2739560B1/en
Priority to PCT/FR1996/001566 priority patent/WO1997013524A1/en
Priority to AU73035/96A priority patent/AU7303596A/en
Publication of FR2739560A1 publication Critical patent/FR2739560A1/en
Application granted granted Critical
Publication of FR2739560B1 publication Critical patent/FR2739560B1/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70535—Fc-receptors, e.g. CD16, CD32, CD64 (CD2314/705F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FR9511860A 1995-10-09 1995-10-09 USE OF A POLYPEPTIDE HAVING SOLUBLE HUMAN CD16 ACTIVITY IN THE TREATMENT OF HIV VIRUS INFECTION Expired - Fee Related FR2739560B1 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
FR9511860A FR2739560B1 (en) 1995-10-09 1995-10-09 USE OF A POLYPEPTIDE HAVING SOLUBLE HUMAN CD16 ACTIVITY IN THE TREATMENT OF HIV VIRUS INFECTION
PCT/FR1996/001566 WO1997013524A1 (en) 1995-10-09 1996-10-08 Use of a polypeptide having soluble human cd16 activity for treating hiv infection
AU73035/96A AU7303596A (en) 1995-10-09 1996-10-08 Use of a polypeptide having soluble human cd16 activity for treating hiv infection

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9511860A FR2739560B1 (en) 1995-10-09 1995-10-09 USE OF A POLYPEPTIDE HAVING SOLUBLE HUMAN CD16 ACTIVITY IN THE TREATMENT OF HIV VIRUS INFECTION

Publications (2)

Publication Number Publication Date
FR2739560A1 FR2739560A1 (en) 1997-04-11
FR2739560B1 true FR2739560B1 (en) 1997-11-21

Family

ID=9483376

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9511860A Expired - Fee Related FR2739560B1 (en) 1995-10-09 1995-10-09 USE OF A POLYPEPTIDE HAVING SOLUBLE HUMAN CD16 ACTIVITY IN THE TREATMENT OF HIV VIRUS INFECTION

Country Status (3)

Country Link
AU (1) AU7303596A (en)
FR (1) FR2739560B1 (en)
WO (1) WO1997013524A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1006183A1 (en) 1998-12-03 2000-06-07 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Recombinant soluble Fc receptors

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0343950B1 (en) * 1988-05-27 2000-10-18 Applied Research Systems ARS Holding N.V. Human receptor Fc(gamma)RIII
FR2655269B1 (en) * 1989-12-01 1994-02-11 Curie Universite Pierre Marie PROTEINS PREVENTING THE INTERACTION BETWEEN A FRAGMENT OF AN IMMUNOGLOBULIN AND ITS RECEPTOR AND USE IN THERAPEUTICS, ESPECIALLY IN THE TREATMENT OF CONDITIONS RELATED TO HIV VIRUSES.
US5198342A (en) * 1990-07-05 1993-03-30 Immunex Corporation DNA encoding IgA Fc receptors
FR2702481B1 (en) * 1993-03-09 1995-04-28 Roussel Uclaf New soluble human Fc-gamma III receptors, their preparation process, the pharmaceutical compositions containing them, their application as medicaments and their diagnostic application.

Also Published As

Publication number Publication date
AU7303596A (en) 1997-04-30
WO1997013524A1 (en) 1997-04-17
FR2739560A1 (en) 1997-04-11

Similar Documents

Publication Publication Date Title
GB2213823B (en) Synthetic peptides for use in the diagnosis and prevention of influenza virus infection
DE3787720D1 (en) DISTRIBUTION PIECE AND CONNECTING ELEMENTS OF A SURGICAL ULTRASONIC SUCTION SYSTEM FOR COMBINED RINSING AND SUCTION.
DE3850492T2 (en) SURGICAL IRRIGATION AND SUCTION SYSTEM.
DE69434865D1 (en) Patient Care System
DE69331617T2 (en) Membrane blood oxygenator
DE3785388D1 (en) ANTIVIRAL PEPTIDES AND AGENTS FOR THE TREATMENT OF HERPES.
FR2643557B1 (en) USE OF N-ACYLCYSTEINS IN THE TREATMENT OF DISEASES ASSOCIATED WITH HIV INFECTIONS
FR2647675B1 (en) USE OF A STATINE DERIVATIVE IN THE TREATMENT OF EYE CONDITIONS
DE69208537D1 (en) Blood separation preparations
MA24332A1 (en) USE OF 1-HYDROXY-2- PYRIDONES FOR THE TREATMENT OF SKIN INFECTIONS
KR950703360A (en) THERAPUTIC AGENT FROM MYCOBACTERRIUM VACCAE AND ITS USE AGAINST HIV INFECTION
BR8907109A (en) TREATMENT OF RODIUM CATALYSTS
ATE94760T1 (en) SULPHATED VINYL POLYMERS IN PREPARATIONS FOR THE TREATMENT OF RETROVIRAL INFECTIONS.
FI944561A0 (en) HIV-neutralizing recombinant human monoclonal antibodies for the prevention and treatment of HIV infection
FR2739560B1 (en) USE OF A POLYPEPTIDE HAVING SOLUBLE HUMAN CD16 ACTIVITY IN THE TREATMENT OF HIV VIRUS INFECTION
DE69322564D1 (en) Artificial blood vessel
AU632545B2 (en) Hog cholera virus vaccine and diagnostic
FR2684552B1 (en) USE OF D-FENFLURAMINE AND FENFLURAMINE DERIVATIVES IN THE TREATMENT OF HYPERTENSION IN INSULIN RESISTANT SUBJECTS.
MC2246A1 (en) USE OF TRINITROBENZENES OR CARMINIC ACID IN THE TREATMENT OF CANCER OR VIRAL DISEASES
FI963638A (en) Procedures for the diagnosis and treatment of HIV-1 infection
FR2641463B1 (en) COSMETIC PREPARATIONS FOR OXYGENATION OF THE SKIN
AU5836390A (en) Human lymphoma-associated virus
FR2702149B1 (en) Application of lamotrigine in the treatment of neuro-AIDS.
AU2695588A (en) Peptides, a process for the preparation thereof, the use thereof for obtaining antibodies, and the use thereof for blocking pai 1 activity in human blood
FR2584922B1 (en) HUMAN BODY ELONGATION TABLE

Legal Events

Date Code Title Description
TP Transmission of property
ST Notification of lapse